 

The transcript discusses the financial performance of West, a global healthcare company, in the first quarter of 2020. Despite the challenges posed by the COVID-19 pandemic, West has continued to focus on two priorities: the well-being and safety of its team members and the continuity of manufacturing and supply of components and solutions to customers. The company has experienced strong growth in the first quarter, with 13% organic sales growth and double-digit growth in adjusted earnings per share. West's gross profit margin has also improved, driven by the growth in high-value products and production efficiencies. The company's full-year 2020 net sales guidance remains in a range of between $1.95 billion and $1.97 billion, with an estimated headwind of $26 million based on current foreign exchange rates. West is committed to supporting the healthcare industry in resolving the global pandemic and emerging from the experience stronger.